These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28185119)

  • 21. Biallelic FANCD1/BRCA2 mutations predisposing to glioblastoma multiforme with multiple oncogenic amplifications.
    Dodgshun AJ; Sexton-Oates A; Saffery R; Sullivan MJ
    Cancer Genet; 2016; 209(1-2):53-6. PubMed ID: 26740091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
    García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
    Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-links between Fanconi anaemia and BRCA2.
    West SC
    DNA Repair (Amst); 2003 Feb; 2(2):231-4. PubMed ID: 12531392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutations.
    Radulovic I; Schündeln MM; Müller L; Ptok J; Honisch E; Niederacher D; Wiek C; Scheckenbach K; Leblanc T; Larcher L; Soulier J; Reinhardt D; Schaal H; Andreassen PR; Hanenberg H
    Hum Mol Genet; 2023 May; 32(11):1836-1849. PubMed ID: 36721989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fanconi anemia: correlating central nervous system malformations and genetic complementation groups.
    Johnson-Tesch BA; Gawande RS; Zhang L; MacMillan ML; Nascene DR
    Pediatr Radiol; 2017 Jun; 47(7):868-876. PubMed ID: 28283722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fanconi Anaemia, Childhood Cancer and the
    Woodward ER; Meyer S
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric acute promyelocytic leukemia and Fanconi anemia: Case report and literature review.
    Freycon C; Sepulchre E; Lavallée VP; Mitchell D; MacMillan ML; Vezina C; Goudie C
    Clin Genet; 2024 Aug; 106(2):193-198. PubMed ID: 38658784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homozygous loss of function BRCA1 variant causing a Fanconi-anemia-like phenotype, a clinical report and review of previous patients.
    Freire BL; Homma TK; Funari MFA; Lerario AM; Leal AM; Velloso EDRP; Malaquias AC; Jorge AAL
    Eur J Med Genet; 2018 Mar; 61(3):130-133. PubMed ID: 29133208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
    Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
    Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catastrophic chemotherapy toxicity leading to diagnosis of Fanconi anaemia due to
    Ip E; McNeil C; Grimison P; Scheinberg T; Tudini E; Ho G; Scott RJ; Brown C; Sandroussi C; Guitera P; Spurdle AB; Goodwin A
    J Med Genet; 2022 Sep; 59(9):912-915. PubMed ID: 34697207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
    Sawyer SL; Tian L; Kähkönen M; Schwartzentruber J; Kircher M; ; ; Majewski J; Dyment DA; Innes AM; Boycott KM; Moreau LA; Moilanen JS; Greenberg RA
    Cancer Discov; 2015 Feb; 5(2):135-42. PubMed ID: 25472942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia.
    Wagner JE; Tolar J; Levran O; Scholl T; Deffenbaugh A; Satagopan J; Ben-Porat L; Mah K; Batish SD; Kutler DI; MacMillan ML; Hanenberg H; Auerbach AD
    Blood; 2004 Apr; 103(8):3226-9. PubMed ID: 15070707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
    Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H
    Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.
    Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
    Lakhi NA; Mizejewski GJ
    Fetal Pediatr Pathol; 2017 Feb; 36(1):49-61. PubMed ID: 27690720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between FANCD1/BRCA2 mutations and leukaemia.
    Alter BP
    Br J Haematol; 2006 May; 133(4):446-8; author reply 448. PubMed ID: 16643458
    [No Abstract]   [Full Text] [Related]  

  • 40. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.
    Esteban-Jurado C; Franch-Expósito S; Muñoz J; Ocaña T; Carballal S; López-Cerón M; Cuatrecasas M; Vila-Casadesús M; Lozano JJ; Serra E; Beltran S; Brea-Fernández A; Ruiz-Ponte C; Castells A; Bujanda L; Garre P; Caldés T; Cubiella J; Balaguer F; Castellví-Bel S
    Eur J Hum Genet; 2016 Oct; 24(10):1501-5. PubMed ID: 27165003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.